A winter virus jab for babies could ease the burden on the NHS, scientists have said, after a large clinical trial has shown it can reduce related hospital admissions by more than 80%.
Results from the Harmonie study suggest a single shot of nirsevimab offers immediate protection against RSV (Respiratory Syncytial Virus) – a common seasonal virus that affects 90% of children worldwide before the age of two.
